Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

IMPORTANCE: Programmed cell death (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors have been increasingly used in cancer therapy. Understanding the treatment-related adverse events of these drugs is critical for clinical practice. OBJECTIVE: To evaluate the incidences of treatment-relate...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:JAMA Oncol
Huvudupphovsmän: Wang, Yucai, Zhou, Shouhao, Yang, Fang, Qi, Xinyue, Wang, Xin, Guan, Xiaoxiang, Shen, Chan, Duma, Narjust, Vera Aguilera, Jesus, Chintakuntlawar, Ashish, Price, Katharine A., Molina, Julian R., Pagliaro, Lance C., Halfdanarson, Thorvardur R., Grothey, Axel, Markovic, Svetomir N., Nowakowski, Grzegorz S., Ansell, Stephen M., Wang, Michael L.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Medical Association 2019
Ämnen:
Original Investigation
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487913/
https://ncbi.nlm.nih.gov/pubmed/31021376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.0393
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk